Steven Cohen’s Mirum Pharmaceuticals MIRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-6,600
Closed -$773K – 4327
2026
Q2
$773K Hold
6,600
– – ﹤0.01% 2968
2026
Q1
$610K Sell
6,600
-1,600
-20% -$151K ﹤0.01% 3037
2025
Q4
$648K Buy
+8,200
New +$589K ﹤0.01% 3104

Other funds holding MIRM

Steven Cohen's MIRM Position: Q3 2026 in Review

Steven Cohen opened a new position in Mirum Pharmaceuticals (MIRM) in Q3 2026: 546,005 shares worth $46.7M. The stake represents 0.05% of the portfolio and ranks #485 among its holdings. This is a return to the name: Steven Cohen previously reported a position in MIRM as recently as Q1 2026.

Steven Cohen first reported a position in MIRM in Q2 2020 and has held it in 15 quarters since. The position peaked at $58M in Q3 2025. 317 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.

  • Steven Cohen held 546,005 shares of Mirum Pharmaceuticals worth $46.7M as of Q3 2026.
  • Mirum Pharmaceuticals was a new Steven Cohen position in Q3 2026.
  • Mirum Pharmaceuticals made up 0.05% of Steven Cohen's portfolio in Q3 2026, its #485 holding.
  • Steven Cohen first reported a position in Mirum Pharmaceuticals in Q2 2020 and has held it in 15 quarters since.
  • Steven Cohen's Mirum Pharmaceuticals position peaked at $58M in Q3 2025.
  • 317 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.